GlassScriptPhysician profile
Dillian Lasalle
NPI 1659307569
$4,363.66
in general payments reported to CMS, 2019-2025
46 companies · $804 in 2025
The $804 reported for 2025 was more than what 81% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $815 · 2022: $1,137 · 2023: $599 · 2024: $1,009 · 2025: $804.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,411.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $588.28 | 2021-2024 | |
| Novo Nordisk INC | $450.39 | 2021-2025 | Ozempic, Wegovy, Rybelsus |
| Lilly USA, LLC | $381.71 | 2021-2025 | Mounjaro, Zepbound, Trulicity |
| Pfizer INC. | $333.21 | 2022-2025 | |
| Eisai INC. | $326.35 | 2021-2025 | |
| Kowa Pharmaceuticals America, INC. | $226.97 | 2021-2024 | Livalo, Seglentis |
| Takeda Pharmaceuticals U.S.A., INC. | $170.08 | 2021-2024 | Trintellix |
| Abbott Laboratories | $168.33 | 2021-2024 | Freestyle Libre 2, Freestyle Libre 3, Eterna |
| Paratek Pharmaceuticals, INC. | $144.30 | 2021-2023 | Nuzyra |
| Amgen INC. | $126.38 | 2021-2025 | Evenity, Repatha, Otezla |
| Novartis Pharmaceuticals Corporation | $121.57 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $97.79 | 2021-2023 | |
| Cleerly, INC. | $96.78 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Boehringer Ingelheim Pharmaceuticals, INC. | $96.63 | 2022 | |
| Dexcom, INC. | $86.55 | 2022-2024 | Dexcom G6 Transmitter |
Show all 46 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dillian Lasalle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.